Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
24.52
-0.68 (-2.70%)
Aug 6, 2025, 1:45 PM HKT
HKG:6127 Revenue
Joinn Laboratories(China)Co.,Ltd. had revenue of 287.34M CNY in the quarter ending March 31, 2025, a decrease of -11.54%. This brings the company's revenue in the last twelve months to 1.98B, down -15.05% year-over-year. In the year 2024, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 2.02B, down -15.07%.
Revenue (ttm)
1.98B CNY
Revenue Growth
-15.05%
P/S Ratio
11.40
Revenue / Employee
746.93K CNY
Employees
2,652
Market Cap
24.21B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.02B | -358.15M | -15.07% |
Dec 31, 2023 | 2.38B | 108.52M | 4.78% |
Dec 31, 2022 | 2.27B | 751.29M | 49.54% |
Dec 31, 2021 | 1.52B | 440.78M | 40.97% |
Dec 31, 2020 | 1.08B | 436.53M | 68.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |